摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-chloro-4-(3-formylphenyl)-2-(4-methanesulfonylbenzyl)-1-oxo-1,2-dihydroisoquinoline-3-carboxylic acid methyl ester | 583835-48-7

中文名称
——
中文别名
——
英文名称
6-chloro-4-(3-formylphenyl)-2-(4-methanesulfonylbenzyl)-1-oxo-1,2-dihydroisoquinoline-3-carboxylic acid methyl ester
英文别名
6-chloro-4-(3-formylphenyl)-2-(4-methanesulfonylbenzyl)-1-oxo-1,2-dihydroisoquinoline-3-carboxylic Acid Methyl Ester;methyl 6-chloro-4-(3-formylphenyl)-2-[(4-methylsulfonylphenyl)methyl]-1-oxoisoquinoline-3-carboxylate
6-chloro-4-(3-formylphenyl)-2-(4-methanesulfonylbenzyl)-1-oxo-1,2-dihydroisoquinoline-3-carboxylic acid methyl ester化学式
CAS
583835-48-7
化学式
C26H20ClNO6S
mdl
——
分子量
509.967
InChiKey
PDDBAQMBAWFWNJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.6
  • 重原子数:
    35
  • 可旋转键数:
    7
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    106
  • 氢给体数:
    0
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    6-chloro-4-(3-formylphenyl)-2-(4-methanesulfonylbenzyl)-1-oxo-1,2-dihydroisoquinoline-3-carboxylic acid methyl ester 在 sodium tetrahydroborate 作用下, 以 四氢呋喃甲醇 为溶剂, 以45%的产率得到6-chloro-4-(3-hydroxymethylphenyl)-2-(4-methanesulfonylbenzyl)-1-oxo-1,2-dihydroisoquinoline-3-carboxylic acid methyl ester
    参考文献:
    名称:
    Discovery, synthesis and biological evaluation of isoquinolones as novel and highly selective JNK inhibitors (1)
    摘要:
    A novel series of 4-phenylisoquinolones were synthesized and evaluated as c-Jun N-terminal kinase (JNK) inhibitors. Initial modi. cation at the 2- and 3-positions of the isoquinolone ring of hit compound 4, identified from high-throughput screening, led to the lead compound 6b. The optimization was carried out using a JNK1-binding model of 6b and several compounds exhibited potent JNK inhibition. Among them, 11g significantly inhibited cardiac hypertrophy in rat pressure-overload models without affecting blood pressure and the concept of JNK inhibitors as novel therapeutic agents for heart failure was confirmed. (c) 2008 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2008.02.027
  • 作为产物:
    参考文献:
    名称:
    Jnk inhibitor
    摘要:
    含有异喹啉酮骨架或其盐的JNK抑制剂,例如由以下式表示的化合物:其中环A和环B均为可选取代的苯环,X为—O—,—N═,—NR3—或—CHR3—,R2为酰基,可选的酯化或硫酯化羧基,可选的取代的氨基甲酰基或可选的取代的氨基基团等,破折号表示单键或双键,而R1为氢原子,可选的取代的碳氢基团,可选的取代的杂环基团等。
    公开号:
    US20050148624A1
点击查看最新优质反应信息

文献信息

  • JNK INHIBITOR
    申请人:Takeda Chemical Industries, Ltd.
    公开号:EP1484320A1
    公开(公告)日:2004-12-08
    A JNK inhibitor containing a compound having an isoquinolinone skeleton or a salt thereof, such as a compound represented by the formula wherein ring A and ring B are each an optionally substituted benzene ring, X is -O-, -N=, -NR3- or -CHR3-, R2 is an acyl group, an optionally esterified or thioesterified carboxyl group, an optionally substituted carbamoyl group or an optionally substituted amino group and the like, a broken line shows a single bond or a double bond, and R1 is a hydrogen atom, an optionally substituted hydrocarbon group, an optionally substituted heterocyclic group and the like, and the like.
    一种含有异喹啉酮骨架或其盐的JNK抑制剂,例如由以下公式表示的化合物: 其中环A和环B分别是可选择取代的苯环,X是-O-,-N=,-NR3-或-CHR3-,R2是酰基,可选择酯化或硫酯化的羧基,可选择取代的氨基甲酰基或可选择取代的氨基等,虚线表示单键或双键,R1是氢原子,可选择取代的碳氢基团,可选择取代的杂环基团等。
  • Jnk inhibitor
    申请人:Itoh Fumio
    公开号:US20050148624A1
    公开(公告)日:2005-07-07
    A JNK inhibitor containing a compound having an isoquinolinone skeleton or a salt thereof, such as a compound represented by the formula wherein ring A and ring B are each an optionally substituted benzene ring, X is —O—, —N═, —NR 3 — or —CHR 3 —, R 2 is an acyl group, an optionally esterified or thioesterified carboxyl group, an optionally substituted carbamoyl group or an optionally substituted amino group and the like, a broken line shows a single bond or a double bond, and R 1 is a hydrogen atom, an optionally substituted hydrocarbon group, an optionally substituted heterocyclic group and the like, and the like.
    含有异喹啉酮骨架或其盐的JNK抑制剂,例如由以下式表示的化合物:其中环A和环B均为可选取代的苯环,X为—O—,—N═,—NR3—或—CHR3—,R2为酰基,可选的酯化或硫酯化羧基,可选的取代的氨基甲酰基或可选的取代的氨基基团等,破折号表示单键或双键,而R1为氢原子,可选的取代的碳氢基团,可选的取代的杂环基团等。
  • JNK inhibitor
    申请人:Takeda Pharmaceutical Company Limited
    公开号:US07402595B2
    公开(公告)日:2008-07-22
    A JNK inhibitor containing a compound having an isoquinolinone skeleton or a salt thereof, such as a compound represented by the formula wherein ring A and ring B are each an optionally substituted benzene ring, X is —O—, —N═, —NR3— or —CHR3—, R2 is an acyl group, an optionally esterified or thioesterified carboxyl group, an optionally substituted carbamoyl group or an optionally substituted amino group and the like, a broken line shows a single bond or a double bond, and R1 is a hydrogen atom, an optionally substituted hydrocarbon group, an optionally substituted heterocyclic group and the like, and the like.
    一种含有异喹啉酮骨架或其盐的JNK抑制剂,例如由下式表示的化合物:其中环A和环B均为可选取代的苯环,X为—O—、—N═、—NR3—或—CHR3—,R2为酰基、可选酯化或硫酯化的羧基、可选取代的氨基甲酰基或可选取代的氨基基团等,破折号表示单键或双键,R1为氢原子、可选取代的碳氢基团、可选取代的杂环基团等。
  • US7402595B2
    申请人:——
    公开号:US7402595B2
    公开(公告)日:2008-07-22
  • Discovery, synthesis and biological evaluation of isoquinolones as novel and highly selective JNK inhibitors (1)
    作者:Yasutomi Asano、Shuji Kitamura、Taiichi Ohra、Kazuyoshi Aso、Hideki Igata、Tomoko Tamura、Tomohiro Kawamoto、Toshimasa Tanaka、Satoshi Sogabe、Shin-ichi Matsumoto、Masashi Yamaguchi、Hiroyuki Kimura、Fumio Itoh
    DOI:10.1016/j.bmc.2008.02.027
    日期:2008.4
    A novel series of 4-phenylisoquinolones were synthesized and evaluated as c-Jun N-terminal kinase (JNK) inhibitors. Initial modi. cation at the 2- and 3-positions of the isoquinolone ring of hit compound 4, identified from high-throughput screening, led to the lead compound 6b. The optimization was carried out using a JNK1-binding model of 6b and several compounds exhibited potent JNK inhibition. Among them, 11g significantly inhibited cardiac hypertrophy in rat pressure-overload models without affecting blood pressure and the concept of JNK inhibitors as novel therapeutic agents for heart failure was confirmed. (c) 2008 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-N'-亚硝基尼古丁 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非尼拉朵 非尼拉敏 阿雷地平 阿瑞洛莫 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 锇二(2,2'-联吡啶)氯化物 链黑霉素 链黑菌素 银杏酮盐酸盐 铬二烟酸盐 铝三烟酸盐 铜-缩氨基硫脲络合物 铜(2+)乙酸酯吡啶(1:2:1) 铁5-甲氧基-6-甲基-1-氧代-2-吡啶酮 钾4-氨基-3,6-二氯-2-吡啶羧酸酯 钯,二氯双(3-氯吡啶-κN)-,(SP-4-1)-